risedronic acid has been researched along with Colitis, Granulomatous in 5 studies
Risedronic Acid: A pyridine and diphosphonic acid derivative that acts as a CALCIUM CHANNEL BLOCKER and inhibits BONE RESORPTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with Crohn's disease have an increased frequency of osteopenia and osteoporosis." | 2.77 | Risedronate improves bone mineral density in Crohn's disease: a two year randomized controlled clinical trial. ( Fedorak, RN; McQueen, B; Siffledeen, J; Siminoski, K; Soo, I, 2012) |
| " A random-effects model within a Bayesian framework was applied to compare treatment effects as standardized mean difference (SMD) with their corresponding 95% credible interval (CrI), while odds ratio (OR) was applied to compare adverse events with 95% CrI." | 2.55 | Efficacy and safety of medical therapy for low bone mineral density in patients with Crohn disease: A systematic review with network meta-analysis. ( Chen, H; Ma, H; Ma, J; Wang, P; Zhang, H; Zhang, Y; Zhao, X; Zhou, C; Zhu, Y, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| van Bodegraven, AA | 1 |
| Bravenboer, N | 1 |
| Witte, BI | 1 |
| Dijkstra, G | 1 |
| van der Woude, CJ | 1 |
| Stokkers, PC | 1 |
| Russel, MG | 1 |
| Oldenburg, B | 1 |
| Pierik, M | 1 |
| Roos, JC | 1 |
| van Hogezand, RA | 1 |
| Dik, VK | 1 |
| Oostlander, AE | 1 |
| Netelenbos, JC | 1 |
| van de Langerijt, L | 1 |
| Hommes, DW | 1 |
| Lips, P | 1 |
| Bernstein, CN | 1 |
| Targownik, LE | 1 |
| Leslie, WD | 1 |
| Zhao, X | 1 |
| Zhou, C | 1 |
| Chen, H | 1 |
| Ma, J | 1 |
| Zhu, Y | 1 |
| Wang, P | 1 |
| Zhang, Y | 1 |
| Ma, H | 1 |
| Zhang, H | 1 |
| Soo, I | 1 |
| Siffledeen, J | 1 |
| Siminoski, K | 1 |
| McQueen, B | 1 |
| Fedorak, RN | 1 |
| Namazi, H | 1 |
1 review available for risedronic acid and Colitis, Granulomatous
| Article | Year |
|---|---|
Efficacy and safety of medical therapy for low bone mineral density in patients with Crohn disease: A systematic review with network meta-analysis.
Topics: Alendronate; Bayes Theorem; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic | 2017 |
2 trials available for risedronic acid and Colitis, Granulomatous
| Article | Year |
|---|---|
Treatment of bone loss in osteopenic patients with Crohn's disease: a double-blind, randomised trial of oral risedronate 35 mg once weekly or placebo, concomitant with calcium and vitamin D supplementation.
Topics: Absorptiometry, Photon; Adult; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabo | 2014 |
Risedronate improves bone mineral density in Crohn's disease: a two year randomized controlled clinical trial.
Topics: Absorptiometry, Photon; Adult; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabo | 2012 |
2 other studies available for risedronic acid and Colitis, Granulomatous
| Article | Year |
|---|---|
What is the role for bisphosphonates in IBD?
Topics: Bone Density Conservation Agents; Bone Diseases, Metabolic; Calcium; Crohn Disease; Dietary Suppleme | 2014 |
Risedronate improves bone mineral density in Crohn's disease: a complementary mechanism.
Topics: Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Crohn Disease; Etidronic A | 2012 |